Defense Stock Domin...
Health Care: Drugs
Targacept Inc. (TRGT: NASDAQ)
$5.60 0.14 | 2.47%
05/24/13 - 02:05 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 5.46 |
| 52 Week High | 5.69 |
| 52 Week Low | 3.85 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 1.78 |
| Share Related Items | |
| Mkt Cap (Mil) | 183.56 |
| Shares Out (Mil) | 33.62 |
| Float (Mil) | 19.80 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 13.00 |
| Current Ratio | 13.30 |
| LT Debt/ Equity | 0.01 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.76 |
| Price/Book | 1.08 |
| Price/Cash Flow | -14.90 |
| Per Share Data | |
| Earnings | -0.52 |
| Sales | 1.15 |
| Book Value | 5.04 |
| Cash Flow | -0.37 |
| Business Summary | |
|---|---|
| A biopharmaceutical company, which is engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of diseases and disorders of the central nervous system. | |
| General Information | |
| 200 East 1st Street
Suite 300 Winston-Salem, NC 27101-4165 |
|
| www.targacept.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 40 | |
| CEO: Stephen A. Hill,B.M. | |
| Short Interest | |
| Current Month (Mil) | 2.30 |
| Previous Month (Mil) | 2.35 |
| Short Interest Ratio (Days) | 15.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -8.40 |
| Return on Investments | -8.80 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -52.10 |
| Profit Margin | -39.10 |
Portfolios with TRGT
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 29
- Userjobeco
- UserFirstval
- UserGFNN Stockdiagnostics 10
- UserMiriam Hoath
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Biotech Stocks Loved and...
- ContributorHot Biotech Trades for Seco...
- UserMoney
- UserBVF Inc.
Latest TRGT Headlines from TheStreet
- Three Cheers For Alkermes Running A Depression Study In The US of A 04.17.13 | 10:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- Insider Trading TPCA JCP TRGT GLW 11.20.12 | 10:11 am
- The Targacept Secret That Wall Street Doesn't Want You to Know About 09.18.12 | 07:09 am
- Targacept Stock Hits New 52-Week Low (TRGT) 05.18.12 | 10:05 am
- Targacept Stock Hits New 52-Week Low (TRGT) 04.09.12 | 12:04 pm
- Targacept Stock Gaps Down On Today's Open (TRGT) 03.20.12 | 10:03 am
- Stocks to Watch: Tiffany, Adobe, Targacept (Update 1) 03.20.12 | 08:03 am
Press Releases for TRGT
- Targacept Announces Changes To Board Of Directors And Management - Business Wire 03.18.13 | 04:03 pm
- Targacept And AstraZeneca Amend Collaboration - Business Wire 03.05.13 | 07:03 am
- Targacept To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 08:02 am
- Targacept Reports Fourth Quarter And 2012 Financial Results - Business Wire 02.13.13 | 04:02 pm
- Targacept To Report Fourth Quarter And 2012 Financial Results On February 13, 2013 - Business Wire 02.06.13 | 08:02 am
- Targacept To Present At The 15th Annual BIO CEO & Investor Conference - Business Wire 02.04.13 | 08:02 am
- Targacept To Present At The 2012 Deutsche Bank DbAccess BioFEST - Business Wire 11.27.12 | 08:11 am
- Targacept Appoints Stephen A. Hill, M.D., President And Chief Executive Officer - Business Wire 11.15.12 | 08:11 am
- Targacept Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 04:11 pm
- Targacept To Report Third Quarter 2012 Financial Results On November 6, 2012 - Business Wire 11.01.12 | 08:11 am
Partner Headlines for TRGT
- Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619 - Benzinga 04.18.13 | 09:04 am
- 5 Beaten Up Stocks That Insiders Think Can Rebound - Seeking Alpha 04.13.13 | 09:04 am
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- Targacept Says Hill Named CEO - Benzinga 11.15.12 | 08:11 am
- Targacept's ADHDi Candidate Fails - Analyst Blog - NASDAQ 09.20.12 | 10:09 pm
- Targacept's ADHDi Candidate Fails - Analyst Blog - Zacks 09.20.12 | 06:09 pm
- Morning Market Losers - Benzinga 09.17.12 | 09:09 am
- Healthcare Business Review: Vivus DISSED By Citron, Lundbeck, et al Have OPPORTUNITY - Wall St. Cheat Sheet 07.20.12 | 08:07 am
- Why Should You Invest Only in High-Quality Companies? - GuruFocus 06.14.12 | 08:06 pm
- Morning Market Losers - Benzinga 03.20.12 | 09:03 am
